Comparison of early and late 68Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas

被引:2
|
作者
Hoppner, Jorge [1 ]
van Genabith, Levin [1 ]
Hielscher, Thomas [2 ]
Heger, Ulrike [3 ]
Sperling, Lucas [3 ]
Colbatzky, Teresa [3 ]
Gutjahr, Ewgenija [4 ]
Lang, Matthias [3 ]
Pausch, Thomas [3 ]
Spektor, Anna-Maria [1 ]
Glatting, Frederik M. [5 ]
Liermann, Jakob [6 ]
Hackert, Thilo [3 ]
Kratochwil, Clemens [1 ]
Giesel, Frederik L. [1 ,7 ]
Haberkorn, Uwe [1 ,8 ]
Roehrich, Manuel [1 ,9 ]
机构
[1] Univ Hosp Heidelberg, Dept Nucl Med, Im Neuenheimer Feld 400, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Dept Biostat, Heidelberg, Germany
[3] Univ Hosp Heidelberg, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany
[4] Univ Hosp Heidelberg, Dept Pathol, Heidelberg, Germany
[5] German Canc Res Ctr, Clin Cooperat Unit Mol Radiat Oncol, Heidelberg, Germany
[6] Univ Hosp Heidelberg, Dept Radiat Oncol, Heidelberg, Germany
[7] Univ Hosp Dusseldorf, Dept Nucl Med, Dusseldorf, Germany
[8] German Canc Res Ctr, Clin Cooperat Unit Nucl Med, Heidelberg, Germany
[9] Univ Hosp Mainz, Dept Nucl Med, Langenbeckstr 1, D-55131 Mainz, Germany
关键词
PET/CT; CANCER;
D O I
10.1038/s41598-023-43049-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Positron emission tomography with (68)Gallium (Ga-68) labeled inhibitors of fibroblast activation protein (Ga-68-FAPI-PET) is a promising imaging technique for patients with recurrent pancreatic ductal adenocarcinomas (PDAC). To date, it is not clear if different acquisition timepoints for Ga-68-FAPI-PET may result in comparable imaging information and if repetitive Ga-68-FAPI-PET imaging may add diagnostic value to single timepoint acquisition for recurrent PDAC. Here we analyzed retrospectively early (20 min p.i.) and late (60 min p.i.) Ga-68-FAPI-PET imaging using FAPI-46 of 33 patients with possible recurrence of PDAC concerning detection rates and uptake over time of local recurrences, metastases, inflammatory lesions of the pancreas, cholestatic lesions of the liver and reactive tissue. 33 patients with histologically confirmed PDAC after complete or partial resection of the pancreas and possible recurrence were examined by Ga-68-FAPI-46-PET acquired 20- and 60-min post injection (p.i.) of the radiotracer. FAPI-positive lesions were classified as local recurrences, metastases, inflammatory lesions of the pancreas (ILP), cholestatic lesions of the liver and reactive tissue based on histology, PET- and CT-morphology and clinical information. Lesions were contoured, and standardized uptake values (SUVmax and SUVmean) and target-to-background ratios (TBR) were analyzed for both acquisition timepoints. In total, 152 FAPI-positive lesions (22 local relapses, 47 metastases, 26 inflammatory lesions of the pancreas, 28 reactive tissues, and 29 cholestatic lesions) were detected. Detection rates for the early and late acquisition of Ga-68-FAPI-46-PET were almost identical except cholestatic lesions, which showed a higher detection rate at early imaging. SUV parameters and TBRs of ILP significantly decreased over time. Cholestatic lesions showed a tendency towards decreasing uptake. All other types of lesions showed relatively stable uptake over time. Early and late acquisition of Ga-68-FAPI-PET results in comparable imaging information in patients with possible recurrence of PDAC. Two timepoint imaging offers additional diagnostic potential concerning differential diagnoses.
引用
收藏
页数:11
相关论文
共 37 条
  • [31] A comparison of the diagnostic performance of 18F-PSMA-1007 and 68GA-PSMA-11 in the same patients presenting with early biochemical recurrence
    Lengana, Thabo
    Lawal, Ismaheel O.
    Van Rensburg, Charl Janse
    Mokoala, Kgomotso M. G.
    Moshokoa, Evelyn
    Ridgard, Trevino
    Vorster, Mariza
    Sathekge, Mike M.
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2021, 24 (03) : 178 - 185
  • [32] 18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma
    Benz, Matthias R.
    Armstrong, Wesley R.
    Ceci, Francesco
    Polverari, Giulia
    Donahue, Timothy R.
    Wainberg, Zev A.
    Quon, Andrew
    Auerbach, Martin
    Girgis, Mark D.
    Herrmann, Ken
    Czernin, Johannes
    Calais, Jeremie
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (02) : 199 - 204
  • [33] Is there a diagnostic benefit of late-phase abdomino-pelvic PET/CT after urination as part of whole-body 68 Ga-PSMA-11 PET/CT for restaging patients with biochemical recurrence of prostate cancer after radical prostatectomy?
    Janna Morawitz
    Julian Kirchner
    Johannes Hertelendy
    Christina Loberg
    Lars Schimmöller
    Mardjan Dabir
    Lena Häberle
    Eduards Mamlins
    Christina Antke
    Christian Arsov
    Gerald Antoch
    Lino M. Sawicki
    EJNMMI Research, 12
  • [34] 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial
    Calais, Jeremie
    Ceci, Francesco
    Eiber, Matthias
    Hope, Thomas A.
    Hofman, Michael S.
    Rischpler, Christoph
    Bach-Gansmo, Tore
    Nanni, Cristina
    Savir-Baruch, Bital
    Elashoff, David
    Grogan, Tristan
    Dahlbom, Magnus
    Slavik, Roger
    Gartmann, Jeannine
    Nguyen, Kathleen
    Lok, Vincent
    Jadvar, Hossein
    Kishan, Amar U.
    Rettig, Matthew B.
    Reiter, Robert E.
    Fendler, Wolfgang P.
    Czernin, Johannes
    LANCET ONCOLOGY, 2019, 20 (09) : 1286 - 1294
  • [35] Head to head comparison performance of Tc-99m-EDDA/HYNIC-iPSMA SPECT/CT and Ga-68-PSMA-11 PET/CT a prospective study in biochemical recurrence prostate cancer patients
    Osvaldo Garcia-Perez, Francisco
    Davanzo, Jenny
    Lopez-Buenrostro, Sergio
    Santos-Cuevas, Clara
    Ferro-Flores, Guillermina
    Jimenez-Rios, Miguel A.
    Scavuzzo, Anna
    Santana-Rios, Zael
    Medina-Ornelas, Sevastian
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 8 (05): : 332 - 340
  • [36] Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer
    Schmuck, Sebastian
    Nordlohne, Stefan
    von Klot, Christoph-A.
    Henkenberens, Christoph
    Sohns, Jan M.
    Christiansen, Hans
    Wester, Hans-Juergen
    Ross, Tobias L.
    Bengel, Frank M.
    Derlin, Thorsten
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (06) : 960 - 968
  • [37] Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer
    Sebastian Schmuck
    Stefan Nordlohne
    Christoph-A. von Klot
    Christoph Henkenberens
    Jan M. Sohns
    Hans Christiansen
    Hans-Jürgen Wester
    Tobias L. Ross
    Frank M. Bengel
    Thorsten Derlin
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 960 - 968